An Exploratory Study of XP21279 (With Lodosyn®) and Sinemet® in Parkinson's Disease Subjects
Clinical trial NCT00914602 · COMPLETED
Trial details
- NCT number
- NCT00914602
- Sponsor
- XenoPort, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2010-01-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.